Fresenius Medical Net Income Applicable To Common Shares Over Time
| FMS Stock | USD 22.81 0.33 1.47% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Fresenius Medical Performance and Fresenius Medical Correlation. Fresenius |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.525 | Dividend Share 1.19 | Earnings Share 1.18 | Revenue Per Share 32.785 | Quarterly Revenue Growth (0.04) |
The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Applicable To Common Shares Analysis
Compare Fresenius Medical Care and related stocks such as Universal Health Services, Addus HomeCare, and HCA Holdings Net Income Applicable To Common Shares Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UHS | 93.4 M | 398.2 M | 443.4 M | 510.7 M | 545.3 M | 680.5 M | 702.4 M | 752.3 M | 779.7 M | 814.9 M | 944 M | 991.6 M | 674.9 M | 776.1 M | 487.8 M |
| ADUS | 197 K | (2 M) | 7.6 M | 19.1 M | 12.2 M | 11.6 M | 12 M | 13.6 M | 17.5 M | 25.2 M | 33.1 M | 45.1 M | 46 M | 52.9 M | 55.6 M |
| THC | 340 M | 58 M | 141 M | (134 M) | 12 M | (140 M) | (192 M) | (704 M) | 111 M | (232 M) | 399 M | 914 M | 411 M | 369.9 M | 202.1 M |
| SEM | 35.4 M | 107.8 M | 148.2 M | 114.4 M | 120.6 M | 130.7 M | 115.4 M | 177.2 M | 137.8 M | 148.4 M | 259 M | 402.2 M | 153.4 M | 176.4 M | 153 M |
| EHC | 278.5 M | 182.7 M | 160.3 M | 231 M | 215.7 M | 181.5 M | 247.6 M | 256.3 M | 292.3 M | 358.7 M | 284.2 M | 412.2 M | 269.8 M | 310.3 M | 299.1 M |
| PNTG | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 9.9 M | 15.7 M | 2.5 M | 15.7 M | 2.7 M | 6.6 M | 6 M | 7 M |
| INNV | (4.8 M) | (4.8 M) | (4.8 M) | (4.8 M) | (4.8 M) | (4.2 M) | (13.7 M) | (6.5 M) | 19.6 M | 26.3 M | (6.5 M) | (40.7 M) | (40.7 M) | (36.6 M) | (34.8 M) |
| ACHC | 6.7 M | (34.9 M) | 20.5 M | 42.6 M | 83 M | 112.6 M | 6.1 M | 199.8 M | (175.8 M) | 108.9 M | (672.1 M) | 190.6 M | 273.1 M | 245.8 M | 258.1 M |
| ENSG | 22.5 M | 47.7 M | 40.6 M | 24 M | 36 M | 55.4 M | 50 M | 40.5 M | 92.4 M | 110.5 M | 170.5 M | 194.7 M | 224.7 M | 258.4 M | 271.3 M |
| SGRY | (65.9 M) | (65.9 M) | (65.9 M) | (65.9 M) | (65.9 M) | 1.4 M | 9.5 M | (79.1 M) | (238.1 M) | (110.5 M) | (155.6 M) | (81.2 M) | (54.6 M) | (49.1 M) | (51.6 M) |
Fresenius Medical Care and related stocks such as Universal Health Services, Addus HomeCare, and HCA Holdings Net Income Applicable To Common Shares description
The net income that remains after preferred dividends have been deducted, available to common shareholders.My Equities
My Current Equities and Potential Positions
| Fresenius Medical Care | FMS |
| Classification | Healthcare |
| Location | Germany |
| Exchange | New York Stock Exchange |
USD 22.81
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.